Published in Int J Cardiovasc Imaging on July 06, 2011
Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging. Int J Cardiovasc Imaging (2013) 0.75
Right ventricular dysplasia: a report of 24 adult cases. Circulation (1982) 6.54
Arrhythmogenic right ventricular cardiomyopathy. Lancet (2009) 4.46
Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol (1997) 3.64
Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol (2003) 3.52
Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation (2007) 2.56
Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J (2008) 2.05
Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation (2006) 1.82
Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson (2008) 1.45
Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med (2004) 1.42
The value of different electrocardiographic depolarization criteria in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Electrocardiol (2006) 0.97
Sequential regional phase mapping of radionuclide gated biventriculograms in patients with sustained ventricular tachycardia: close correlation with electrophysiologic characteristics. Am Heart J (1982) 0.91
Arrhythmogenic right ventricular dysplasia. Curr Opin Cardiol (1995) 0.87
Prevalence and pathophysiologic attributes of ventricular dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol (2009) 0.84
Diagnosis of diffuse and localized arrhythmogenic right ventricular dysplasia by gated blood-pool SPECT. J Nucl Med (2007) 0.82
Arrhythmogenic right ventricular dysplasia demonstrated by phase mapping of gated equilibrium radioventriculography. Am Heart J (1986) 0.81
Detection and quantification of regional wall motion abnormalities using phase analysis of equilibrium gated cardiac studies. Clin Nucl Med (1983) 0.81
Prognostic value of radionuclide angiography in patients with right ventricular arrhythmias. Circulation (2001) 0.80
Evaluation of radionuclide angiography in diagnosis of arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol (1995) 0.80
Characterization of right or left ventricular contraction heterogeneity using Fourier phase analysis. Application to a group of patients with severe ventricular arrhythmias. Eur J Nucl Med (1988) 0.79
Delayed contraction area responsible for sustained ventricular tachycardia in an arrhythmogenic right ventricular cardiomyopathy: demonstration by Fourier analysis of SPECT equilibrium radionuclide angiography. J Nucl Cardiol (2001) 0.78
Clinical aspects and prognosis of Brugada syndrome in children. Circulation (2007) 2.29
Identification and distribution of interstitial Cajal cells in human pulmonary veins. Heart Rhythm (2008) 1.86
Long-term benefit of postconditioning. Circulation (2008) 1.65
Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ Cardiovasc Imaging (2009) 1.42
Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace (2010) 1.40
Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J (2010) 1.21
Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. Eur J Med Genet (2011) 1.09
Toward personal eHealth in cardiology. Results from the EPI-MEDICS telemedicine project. J Electrocardiol (2005) 1.08
5-Fluorouracil-induced Tako-Tsubo-like syndrome. Pharmacotherapy (2011) 1.03
Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Eur J Med Genet (2010) 1.00
New paradigms in telemedicine: ambient intelligence, wearable, pervasive and personalized. Stud Health Technol Inform (2004) 0.97
Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr Cardiol (2009) 0.90
Sudden death of cardiac origin and psychotropic drugs. Front Pharmacol (2012) 0.89
Design and evaluation of a transesophageal HIFU probe for ultrasound-guided cardiac ablation: simulation of a HIFU mini-maze procedure and preliminary ex vivo trials. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.84
Inflammation, a link between obesity and atrial fibrillation. Inflamm Res (2015) 0.83
Long-standing bacteremia and endocarditis caused by Staphylococcus lugdunensis in a patient with an implantable cardioverter defibrillator. Clin Microbiol Infect (1997) 0.82
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? Eur J Endocrinol (2003) 0.82
Right ventricular pump function after cardiac resynchronization therapy: a strain imaging study. Arch Cardiovasc Dis (2008) 0.82
Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. J Cardiovasc Pharmacol (2008) 0.81
QT interval prolongation in future SIDS victims: a polysomnographic study. Sleep (2008) 0.81
Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients. Europace (2013) 0.80
Radiofrequency ablation of atrial fibrillation: the first 100 cases in Lyon. Int J Cardiol (2008) 0.80
Periatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillation. PLoS One (2013) 0.80
A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope. Heart Rhythm (2008) 0.80
Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation. Europace (2012) 0.80
The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs. J Anesth (2006) 0.79
Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol (2003) 0.79
Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status. Resuscitation (2012) 0.79
Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome. FEBS Lett (2009) 0.79
Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion. Resuscitation (2011) 0.78
Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients: a prospective long-term study. Circ Cardiovasc Imaging (2011) 0.78
Thymic size and muscle mass of HIV-infected asymptomatic children from Burkina Faso. J Acquir Immune Defic Syndr (2002) 0.78
Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am J Physiol Heart Circ Physiol (2012) 0.78
In-hospital heart rate turbulence and microvolt T-wave alternans abnormalities for prediction of early life-threatening ventricular arrhythmia after acute myocardial infarction. Ann Noninvasive Electrocardiol (2013) 0.78
Frequency of atrial tachyarrhythmias in patients treated by cardiac resynchronization (from the Prospective, Multicenter Mona Lisa Study). Am J Cardiol (2010) 0.76
Myocarditis and cardiac channelopathies: a deadly association? Int J Cardiol (2011) 0.76
Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study. Am Heart J (2010) 0.76
High-tech catheter ablation: worth the cost? Arch Cardiovasc Dis (2009) 0.75
Response to letter by Robert M. Hamilton based on "Prophylactic radiofrequency ablation in asymptomatic patients with Wolff-Parkinson-White is not yet a good strategy: a decision analysis" by Chevalier et al. Circ Arrhythm Electrophysiol (2013) 0.75
Scaring myocardial scars: new targets for the electrical fairy? J Am Coll Cardiol (2012) 0.75
Short-coupled variant of torsades de pointes with intractable ventricular fibrillation: lifesaving effect of cardiopulmonary bypass. J Cardiovasc Electrophysiol (2003) 0.75
Persistent abnormal intraventricular conduction after myocarditis revealed by recurrent syncopes. J Electrocardiol (2013) 0.75
Limits of arterial myocardial revascularization. J Card Surg (2003) 0.75
A heartless brain. Europace (2013) 0.75
Effects of amlodipine and perindoprilate on the structure and function of mitochondria in ventricular cardiomyocytes during ischemia-reperfusion in the pig. Fundam Clin Pharmacol (2014) 0.75
[Intracardiac conduction disturbances]. Rev Prat (2012) 0.75
Ventricular muscarinic receptor remodeling in patients with and without primary ventricular fibrillation. An imaging study. J Nucl Cardiol (2012) 0.75
Right superior vena cava drainage into the left atrium revealed by multiples strokes after pacemaker implantation. Heart Rhythm (2012) 0.75
Pneumomediastinum after implantable cardiac defibrillator implantation. Eur Heart J (2010) 0.75
[Recurrent septicaemia following incomplete removal of pacemaker leads]. Presse Med (2005) 0.75
Wavelet transform for analysis of heart rate variability preceding ventricular arrhythmias in patients with ischemic heart disease. Int J Cardiol (2005) 0.75
Accelerated coronary atherosclerosis revealed by arrhythmogenic coronary spasm. Cardiology (2011) 0.75
Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age. Arch Cardiovasc Dis (2011) 0.75
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals. Cochrane Database Syst Rev (2016) 0.75
Pulmonary vein hematoma after atrial fibrillation cryoablation: a new complication. Heart Rhythm (2012) 0.75
Protective effects of ranolazine and propranolol, alone or combined, on the structural and functional alterations of cardiomyocyte mitochondria in a pig model of ischemia/reperfusion. Fundam Clin Pharmacol (2013) 0.75
Monitoring of heart rate variability in heart failure patients with cardiac resynchronisation therapy: interest of continuous and didactic algorithm. Int J Cardiol (2009) 0.75
Spatiotemporal electrocardiographic characterization of ventricular depolarization and repolarization abnormalities in long QT syndrome. J Electrocardiol (2007) 0.75
Ropivacaine combined with various anti-arrhythmic drugs results in mild alterations in myocardial contractility in pigs. Can J Anaesth (2003) 0.75
Beat-to-beat variations of the electrocardiogram in survivors of sudden death without structural heart disease. J Electrocardiol (2006) 0.75